Approval · Notice of Compliance 3585 · 2003
RAPAMUNE: Notice of Compliance 3585
Issued February 10, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3585
- Date
- February 10, 2003
- Company
- Wyeth-Ayerst Canada Inc.St. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form: tablets; new strength: 1 mg
- Therapeutic class
- Immunosuppressive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAPAMUNE | 02247111 | Marketed |
Medicinal ingredients
- SIROLIMUS 1 MG per TAB